The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable angina

European Journal of Internal Medicine

Volumn 15, Issue 5, 2004, Pages 291-297

  Tanaseanu, Cristina ^a   Moldoveanu, Elena ^b   Kosaka, Tetsuya ^c   Tanaseanu, Stefanita ^d   Neagu, Monica ^b   Popescu, Laurentiu M ^b  

^a Bucharest Romania   (Romania)

^b Victor Babesa Natl Inst R D P   (United States)

^c R and D Division   (Japan)

^d Carol Davila School of Medicine   (Romania)

Author keywords

Inflammation; Neutrophils; Platelet activating factor acetylhydrolase; Stable angina

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NEUTROPHIL; OXYGEN BLOOD LEVEL; PHAGOCYTOSIS; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE;

EID: 4644327537     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2004.06.002     Document Type: Article

References (38)

1. R. Ross Atherosclerosis an inflammatory disease N. Engl. Med. 340 1999 115 126
2. R.J. Chilton Recent discoveries in assessment of coronary heart disease: impact of vascular mechanisms on development of atherosclerosis J. Am. Osteopath. Assoc. 101 Suppl. 9 2001 S1 S5
3. A. Hoffmeister, D. Rothenbacher, and U. Bazner Role of novel markers of inflammation in patients with stable coronary heart disease Am. J. Cardiol. 87 2001 262 266
4. M. Haidari, E. Javadi, and B. Sadeghi Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease Clin. Biochem. 34 2001 309 315
5. E.N. Morgan, E.M. Boyle, and W. Yun Platelet-activating factor-acetylhydrolase prevents myocardial ischemia reperfusion injury Circulation 100 1999 365 368
6. H. Vink, A. Constantinescu, and J. Spaan Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion Circulation 101 2000 1500 1502
7. D. Tribble, M. Rizzo, and A. Chait Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins Am. J. Med. 110 2001 103 110
8. A. Matsuzawa, K. Hattori, and J. Aoki Protection against oxidative stress induced cell death by intracellular platelet-activating factor-acetylhydrolase II J. Biol. Chem. 272 1997 32315 32320
9. 2 J. Biochem. 131 2002 285 292
10. V. Tsimihodimos, S.A. Karabina, and A.P. Tambaki Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia J. Lipid Res. 43 2002 256 263
11. R. Quarck, B. De Geest, and D. Stengel Adenovirus mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice Circulation 103 2001 2495 2500
12. 2 as an independent predictor of coronary heart disease N. Engl. J. Med. 343 2000 1148 1155
13. B.R. Chaitman Exercise stress testing E. Braunwald D.P. Zipes P. Libby Heart disease a text book of cardiovascular medicine 6th ed. 2001 W.B. Sounders Philadelphia 129 204
14. T. Kosaka, M. Yamaguchi, and Y. Soda Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity Clin. Chim. Acta 296 2000 151 161
15. T. Kosaka, M. Yamaguchi, and K. Miyanaga Serum platelet-activating factor acetylhydrolase (PAF-AH) activity in more than 3000 healthy Japanese Clin. Chim. Acta 312 2001 179 183
16. A. Boyum Isolation of mononuclear cell and granulocytes from human blood Scand. J. Clin. Lab. Invest., Suppl. 97 1968 77 89
17. P.J. Lachman, M.J. Hobart, and W.P. Astor Complement technology D.M. Weir Handbook of experimental immunology Sec. ed. 1973 Blackwell Scientific Publication Oxford 6
18. R.B. Johnston, C.A. Godzik, and Z.A. Cohn Increased superoxide anion production by immunologically activated and chemically elicited macrophages J. Exp. Med. 148 1978 115 127
19. A. Olinescu, M. Neagu, and S. Hristescu Action of some proteic and carbohydrate components of Symphytum officinale upon and normal neoplastic cell Rom. Arch. Microbiol. Immunol. 52 1993 73 80
20. J.M. Kremer, R.I. Rynes, and B.L. Bartolomew Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double blind study Am. J. Med. 82 1987 781 786
21. A.M. Gotto Jr. High-density lipoprotein cholesterol: an updated view Curr. Opin. Pharmacol. 1 2001 109 112
22. P. Jousilahti, V. Salomaa, and V. Rasi The association of C-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease-baseline findings of the PAIS project Atherosclerosis 156 2001 451 456
23. B.J. Gersh, E. Braunwald, and R.O. Bonow Chronic coronary artery disease E. Braunwald D.P. Ziper P. Libby Heart diseaseâ€"a textbook of cardiovascular medicine 6th ed. 2001 W.B. Sounders Philadelphia 1272 1353
24. F.D.A. Reid, D.G. Cook, and P.H. Whincup Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart 88 2002 15 19
25. E. Lindmark, L. Wallentin, and A. Siegbahn Blood cells activation, coagulation and inflammation in man and women with coronary artery disease Thromb. Res. 103 2001 249 259
26. I. Ikonomidis, F. Andreotti, and E. Economou Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin Circulation 100 1999 793 798
27. J.F. Keaney, and J.A. Vita The value of inflammation for predicting unstable angina N. Engl. J. Med. 347 2002 55 57
28. A. Buffon, L.M. Biasucci, and G. Liuzzo Widespread coronary inflammation in unstable angina N. Engl. J. Med. 347 2002 5 12
29. S. Takeshita, T. Isshiki, and M. Ochiai Systemic inflammatory responses in acute coronary syndrome: increased activity observed in polymorphonuclear leukocytes but not T lymphocytes Atherosclerosis 135 1997 187 192
30. N.T. Mulvihill, and J.B. Foley Inflammation in acute coronary syndromes Heart 87 2002 201 204
31. P. Cavallo-Perin, E. Lupia, and G. Gruden Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria Nephrol. Dial. Transplant. 15 2000 994 999
32. E. Roth Oxygen frees radicals and their clinical implication Acta Chir. Hung. 36 1997 302 305
33. H.J. Forman, and M. Torres Redox signaling in macrophages Mol. Aspects Med. 22 2001 189 216
34. M. Hirsh, E. Mahamid, and Y. Bashenko Overexpression of the high affinity FcÎ receptor (CD64) is associated with leukocyte dysfunction in sepsis Shock 16 2001 102 108
35. S. Ehara, M. Ueda, and T. Naruko Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 2001 1955 1960
36. P. Holvoet, J. Vanhaecke, and S. Janssens Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease Circulation 98 1998 1487 1494
37. 2: a potential new risk factor for coronary artery disease and a therapeutic target Curr. Opin. Pharmacol. 1 2001 121 125
38. S. Nakamura Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in Japan J. Vasc. Surg. 32 2000 263 267